Madeline Colli

Our sister publication, Oncology Nursing News recently published how cannabidiol oil may be useful in helping patients with breast cancer manage tamoxifen-related adverse effects.

Recreational and medical cannabis in Connecticut have profited $22.1 million in sales in March 2023.

New Leaf Ventures Inc. announces their new manufacturing services agreement with Anonymous Buffalo LLC in Washington State through their subsidiary, New Leaf Services LLC.

Suncrafted Cannabis will unveil its Cranberry Sunnies, solventless rosin chews, on April 13 at a special launch party being held from 5pm to 8pm at the Speedwell Tavern, 47 Main Street, Plymouth, MA.

A recent study revealed how nearly 6 out of every 10 neighborhoods are located in close proximity of a cannabis dispensary.

A Washington State House Committee recently amended and then approved a psilocybin bill which will benefit patients.

Senate Bill 47, legalizing medical cannabis, was signed into law in March 2023 by Kentucky Governor Andy Beshear (D).

A new bill is aiming to allow Pennsylvania liquor stores to sell recreational cannabis.

The NBA is giving players the option to invest in the cannabis industry under a new deal.

Our 2023 Portland show features interactive off-site event at ChemHistory, Oregon’s premier compliance laboratory, in an immersive full day experience prior to conference.

Saint Louis University’s (St. Louis, Missouri), Cannabis Science and Operations program received the 2023 Outstanding Program by the University Professional and Continuing Education Association (UPCEA).

In March 2023, Texas lawmakers approved of House Bill 1085.

Physician and cannabis expert, Dr. Peter Grinspoon, has released his new book titled,”Seeing through the Smoke.” In this informative piece of literature, Dr. Grinspoon discusses separating fact from fiction, cannabis research, and a guide on how to use cannabis safely.

Cannabis Patient Care published a wide variety of content throughout 2022—here is just a small snippet of some of the top articles and columns that our readers enjoyed. Click through and see if any of your favorites made the list!

California Senate Public Safety Committee approves of SB-58, legalizing the possession and use of specific psychedelics.

It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2022—including a lot of video interviews from the Cannabis Science Conference series. Here is just a small snippet of some of the top articles, columns, videos, and podcasts that our readers enjoyed. Click through and see if any of your favorites made the list!

Leaf 411 and Mission Dispensaries look to advance cannabis education through their recent membership.

When you think of cannabis, you probably don’t think of horses or the potential medicinal benefit to animals. However, the cannabinoids found in cannabis have been shown to provide similar benefits in animals that are noted with human patients. In this interview, Emma Davis, founder of Mikko’s Choice, delves into how some cannabinoids—such as tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinolic acid (THCA)—have provided medicinal benefits to horses. Davis also discusses her mustang, Mikko, who inspired her to launch her own cannabis and hemp product brand.

Don't miss this Noid Factoid from Dr. Reggie Gaudino, VP of R&D at Front Range Biosciences.

For more than 20 years, Americans for Safe Access (ASA), the largest national member-based organization of patients, medical professionals, scientists, and citizens, have been advocating for cannabis to be seen as a form of medicine. Here, Steph Sherer and Debbie Churgai of ASA discuss the importance of medical cannabis and how advocacy will light the way forward.

When she was three-and-a-half years old, Brooklyn Hall was diagnosed with anaplastic ependymoma, class 3, a rare and unique form of brain cancer. Here, her mother Meghan Hall shares how Brooklyn’s prognosis drastically changed with the help of Rick Simpson Oil.

In a recent announcement, Major League Baseball announced a sponsorship deal with cannabidiol (CBD) company Charlotte’s Web.

Dr. Anthony Macherone of Agilent Technologies shares what he learned at Cannabis Science Conference East 2022.

Dr. Anthony Macherone of Agilent Technologies discusses what he hopes to see change in the future regarding cannabis regulations and testing guidelines.

Dr. Stephen Barnhill, founder, chairman, and CEO of Apollon Formularies, plc., explained to Cannabis Science Conference East 2022 attendees, his findings on how cannabis and mushrooms can be the ultimate weapon in the war against cancer.

Dr. Anthony Macherone of Agilent Technologies discusses some of the unique challenges when developing testing methods for cannabis products.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

When a patient isn’t able to access the care or medication that they need in their home country, they aren’t left with much of a choice but to travel to a country that will give them the treatment they need. In part II of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), continues discussing her journey to health, the broken healthcare system hurting medical cannabis patients in the US, and what needs to change to make access better for patients.

In early June 2022, the New York State Senate approved a bill which mandated public health insurance programs to cover medical cannabis expenses and defined how private insurers are allowed to handle these expenses as well (1).